10 Best Low Cost Stocks to Buy According to Billionaires
Markets are wobbling, and panic is becoming the headline. At times when stocks are tumbling, headlines are filled with forecasts that cause anxiety for investors. But it's not new.
Immunovant Inc. (IMVT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 6,000,000 | $148,620,000 | +39% | 5.54% |
| 2. | Armistice Capital Steven Boyd | 3,870,586 | $95,874,415 | +10% | 1.3% |
| 3. | Perceptive Advisors Joseph Edelman | 2,139,199 | $52,987,959 | -11% | 1.46% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,707,881 | $42,304,212 | +40% | 0.45% |
| 5. | Two Seas Capital Sina Toussi | 1,511,614 | $37,442,679 | +124% | 3.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 16,845,010 | 96,650,341 | 2025-01-13 | Filing | ||
| $38.00 | 1,526,316 | 79,805,331 | 2023-10-02 | Filing | ||
| $6.00 | 416,667 | 73,805,331 | 2022-10-06 | Filing | ||
| $5.60 | 15,000 | Director | 20,000 | 2022-09-30 | Filing | |
| $5.81 | 20,000 | Director | 393,358 | 2022-09-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.79 | 1,925 | Officer | 209,243 | 2025-04-23 | Filing | |
| $14.79 | 2,349 | Officer | 225,370 | 2025-04-23 | Filing | |
| $14.89 | 2,993 | Officer | 396,774 | 2025-04-16 | Filing | |
| $14.89 | 8,321 | Officer, Director | 1,178,191 | 2025-04-16 | Filing | |
| $12.99 | 28,094 | Officer, Director | 1,186,512 | 2025-04-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 760,608 | $12,998,791 | 0.01% | |
| 2. | 201,911 | $3,450,658 | 0% | |
| 3. | 155,937 | $2,864,563 | 0.01% | |
| 4. | 83,555 | $1,427,940 | 0% | |
| 5. | 18,122 | $309,705 | 0% |
News See All
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US. The Centers for Medicare & Medicaid Services reported that healthcare spending in the US reached $4.9 trillion in 2023, up 7.5% from 2022.
10 Stocks Insiders Spent The Most Money On Recently
As the broader market continues to rise this year, we thought it would be interesting to highlight some stocks that have seen significant insider buying recently.
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Worst Performing Stocks to Buy on the Dip
Capital markets demonstrated increased volatility starting in August 2024 and continuing in September 2024. That being said, strong rallies followed numerous negative performance days.
Should You Hold Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Billionaire Steve Cohen and Insiders are Buying These 5 Stocks
This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire Steve Cohen and Insiders ...
Billionaire Hedge Funds
